The relatively low uptake of [18F]FLT in cancer cells is partly due to the fact that cells do not express a specialised transporter to facilitate its transport across the cell membrane; [18F]FLT either enters cells via the general nucleoside transporter hENT1 or via passive diffusion [50]. This evidence concerns the gene SLC29A1 and cancer.